Advertisement
News
Advertisement

TPI Presents at the 2nd Annual OneMed China Forum on January 9th, 2012 in San Francisco

Fri, 12/23/2011 - 8:39am
Bio-Medicine.Org

CHENGDU, China, Dec. 23, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, has been invited to present at the Second Annual China Forum of the Fifth Annual OneMedForum San Francisco 2012 on January 9, 2012, at Sir Francis Drake Hotel at 450 Powell Street, San Francisco, CA 94102.

About OneMedForum

The OneMedForum San Francisco conference, launched in 2008, runs concurrently with J.P Morgan conference that provides an efficient access to the companies that shape the future of the rapidly changing healthcare landscape with company presentations, panels and workshops for strategic insights and practical benefits.

The 2nd Annual China Forum will take place on Monday, January 9, 2012 at 1:00-4:00 pm at the Sir Francis Drake Hotel in San Francisco, as part of the 5th Annual OneMedForum SF 2012 on January 9-12, 2012.

China Forum II: Pursuing the Healthcare Market in China is designed to help senior executives shape strategy to approach what is one of the most lucrative and perilous markets in the world. The program will consist of four panel sessions that will address critical issues to understanding how Healthcare and life science companies can succeed in China.

Attendees will include institutional investors, senior healthcare executives and life science executives looking for investment opportunities, market insights, licensing opportunities, acquisitions, joint ventures and strategic partnerships.

Additional information regarding the China forum can be found on: www.onemedplace.com/forum/presentation/china-panels

About TPI

Headquartered at Chengdu, C

'/>"/>

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading